Rakovina Therapeutics Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was CAD 0.711953 million compared to CAD 3.2 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.69 a year ago. Diluted loss per share from continuing operations was CAD 0.01 compared to CAD 0.69 a year ago.